Zhitong Finance App News, Nanjing Pharmaceutical (600713.SH) released its report for the first quarter of 2024. During the reporting period, the company achieved operating income of 13.953 billion yuan, a year-on-year decrease of 0.92%; net profit attributable to shareholders of listed companies was 1.59 yuan, an increase of 6.65%; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 154 million yuan, an increase of 3.24% year on year; basic earnings per share were 0.123 yuan.